4
Changes in Ownership
Cogent Biosciences, Inc. Filed Acc 0001193125-25-326772
Chief Legal Officer gave up 125,602 shares (to pay taxes)
- Chief Legal Officer acquired 300,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Kearns Evan · Chief Legal Officer
Table I: Non-derivative
3 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-12-17 | Grant or award : show line 1 in the form | +40,000 | 40,000 | D | ||
| 2025-12-17 | Grant or award : show line 2 in the form | +260,000 | 300,000 | D | ||
| 2025-12-17 | Shares withheld for taxes : show line 3 in the form | −125,602 | $39.45 | $4,954,999 | 174,398 | D |
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2025-12-17 | Grant or award : show line 4 in the form Stock Option (Right to Buy) | +55,000 | 55,000 | D |
Loading xslF345X05/ownership.xml…